Psychiatr Prax 2008; 35(6): 286-293
DOI: 10.1055/s-2007-986385
Originalarbeit

© Georg Thieme Verlag KG Stuttgart · New York

Positivsymptome und Lebensqualität aus der Sicht schizophrener Patienten

Subjective View of Positive Symptoms and Quality of Life in Patients with SchizophreniaAnne  Karow1 , Ingo  Schäfer1 , Florian  Hirdes1 , Claudia  Osterwald1 , Dieter  Naber1
  • 1Zentrum für Psychosoziale Medizin, Klinik für Psychiatrie und Psychotherapie, Universitätsklinikum Hamburg-Eppendorf
Further Information

Publication History

Publication Date:
27 May 2008 (online)

Zusammenfassung

Anliegen Die Untersuchung von Positivsymptomen und Lebensqualität aus der Sicht schizophrener Patienten. Methode Bei 59 Patienten wurden selbst- und fremdbewertete Positivsymptome (semistrukturiertes Interview), Psychopathologie (PANSS), subjektive Befindlichkeit (SWN) und Lebensqualität (MSLQ) untersucht. Ergebnisse Größenideen und dialogisierende Stimmen waren subjektiv weniger beeinträchtigend als imperative, abwertende Stimmen oder Verfolgungsideen. Patienten mit hoher Beeinträchtigung durch ihre Symptome berichteten eine signifikant schlechtere subjektive Befindlichkeit (SWN: t = 2,27; p < 0,05) und Lebensqualität (MSLQ: t = 2,01; p < 0,05), unterschieden sich jedoch nicht hinsichtlich der Schwere ihrer Symptome von Patienten mit geringer Beeinträchtigung (PANSS: t = − 0,98; p = n. s.). Schlussfolgerung Die subjektive Beeinträchtigung durch Positivsymptome spiegelt die individuelle Bedeutung der Symptome wider und ist mit schlechterer Lebensqualität assoziiert.

Abstract

Objective The aim of the study was the investigation of positive symptoms and quality of life from the subjective perspective of patients with schizophrenia. Methods We assessed self- and expert-rated positive symptoms (semi-structured interview), standardized psychopathology (PANSS), subjective well-being (SWN) and QOL (MSLQ) in n = 59 patients. Results Patients reported that ideas of grandiosity and hallucinations of dialogue voices were less distressing compared with command voices, malevolent voices and delusional ideas of persecution. Patients with high levels of distress reported significant lower subjective well-being (SWN: t = 2.27; p < 0.05) and QOL (MSLQ: t = 2.01; p < 0.05), but showed no differences in symptom severity (PANSS: t = − 0,98; p = n. s.) compared with patients with low subjective distress. Conclusions Distress caused by positive symptoms reflected the individual meaning of the symptoms and was associated with lower quality of life.

Literatur

  • 1 Franz M, Meyer T, Gallhofer B. Subjektive Lebensqualität schwer chronifizierter schizophrener Langzeitpatienten.  Psychiat Prax. 2002;  29 306-310
  • 2 Naber D, Lambert M, Karow A. Subjektive Befindlichkeit unter neuroleptischer Behandlung und ihre Bedeutung für Compliance und Krankheitsverlauf.  Psychiat Prax. 2004;  31, Suppl 2 S230-S232
  • 3 Karow A, Naber D. Subjective well-being and quality of life under atypical antipsychotic treatment.  Psychopharmacology. 2002;  162 3-10
  • 4 Lambert M, Schimmelmann B G, Naber D. et al . Prediction of remission as a combination of symptomatic and functional remission and adequate subjective well-being in 2960 patients with schizophrenia.  J Clin Psychiat. 2006;  67 1690-1697
  • 5 Meyer T, Franz M. Vorstellungen zur Lebensqualität schizophren Erkrankter. Der Zusammenhang mit ihren quantitativen Lebensqualitätsurteilen.  Psychiat Prax. 2006;  33 344-349
  • 6 Franz M. Möglichkeiten und Grenzen subjektiver Lebensqualität schizophrener Patienten als Outcomekriterium psychiatrischer Therapie.  Psychiat Prax. 2006;  33 317-322
  • 7 Schmid R, Neuner T, Cording C, Spiessl H. Lebensqualität schizophren Erkrankter und ihr Zusammenhang mit Krankheitsbewältigungsstrategien und Behandlungsaspekten.  Psychiat Prax. 2006;  33 337-343
  • 8 Karow A, Czekalla J, Dittmann R W. et al . Association of subjective well-being, symptoms, and side effects with compliance after 12 months of treatment in schizophrenia.  J Clin Psychiat. 2007;  68 75-80
  • 9 Boitz K, Angermeyer M C, Loffler W, Muller P, Priebe S. „Lieber dick und geistig da …” Patienten beurteilen Clozapin.  Psychiat Prax. 1999;  26 188-193
  • 10 Angermeyer M C, Holzinger A, Matschinger H. Lebensqualität, das bedeutet für mich … Ergebnisse einer Umfrage bei schizophrenen Patienten.  Psychiat Prax. 1999;  26 56-60
  • 11 Hofer A, Kemmler G, Eder U. et al . Quality of life in schizophrenia: the impact of psychopathology, attitude toward medication, and side effects.  J Clini Psychia. 2004;  65 932-939
  • 12 Holzinger A, Loffler W, Muller P, Priebe S, Angermeyer M C. Subjective illness theory and antipsychotic medication compliance by patients with schizophrenia.  J Nerv Ment Dis. 2002;  190 597-603
  • 13 Voruganti L, Cortese L, Oyewumi L. et al . Comparative evaluation of conventional and novel antipsychotic drugs with reference to their subjective tolerability, side-effect profile and impact on quality of life.  Schizophr Res. 2000;  43 135-145
  • 14 Karow A, Moritz S, Lambert M, Schoder S, Krausz M. PANSS syndromes and quality of life in schizophrenia.  Psychopathology. 2005;  38 320-326
  • 15 Huppert J D, Weiss K A, Lim R, Pratt S, Smith T E. Quality of life in schizophrenia: contributions of anxiety and depression.  Schizophr Res. 2001;  51 (2 – 3) 171-180
  • 16 Hofer A, Rettenbacher M A, Widschwendter C G. et al . Correlates of subjective and functional outcomes in outpatient clinic attendees with schizophrenia and schizoaffective disorder.  Eur Arch Psychiatry Clin Neurosci. 2006;  256 (4) 246-255
  • 17 Pukrop R, Schlaak V, Moller-Leimkuhler A M. et al . Reliability and validity of Quality of Life assessed by the Short-Form 36 and the Modular System for Quality of Life in patients with schizophrenia and patients with depression.  Psychiat Res. 2003;  119 63-79
  • 18 Eack S, Newhill C. Psychiatric Symptoms and Quality of Life in Schizophrenia: A Meta-Analysis.  Schizophr Bull. 2007;  33 (5) 1225-1237
  • 19 Eack S M, Newhill C E, Anderson C M, Rotondi A J. Quality of life for persons living with schizophrenia: more than just symptoms.  Psychiat Rehabil J. 2007;  30 219-222
  • 20 Birchwood M, Meaden A, Trower P, Gilbert P, Plaistow J. The power and omnipotence of voices: subordination and entrapment by voices and significant others.  Psychol Med. 2000;  30 337-344
  • 21 Iqbal Z, Birchwood M, Chadwick P, Trower P. Cognitive approach to depression and suicidal thinking in psychosis. 2. Testing the validity of a social ranking model.  Brit J Psychiat. 2000;  177 522-528
  • 22 Garety P A, Freeman D, Jolley S. et al . Reasoning, emotions, and delusional conviction in psychosis.  J Abnorm Psychol. 2005;  114 373-384
  • 23 Green C, Garety P A, Freeman D. et al . Content and affect in persecutory delusions.  Brit J Clin Psychol. 2006;  45 561-577
  • 24 Kuipers E, Garety P, Fowler D. et al . Cognitive, emotional, and social processes in psychosis: refining cognitive behavioral therapy for persistent positive symptoms.  Schizophr Bull. 2006;  32, Suppl 1 S24-31
  • 25 Smith B, Fowler D G, Freeman D. et al . Emotion and psychosis: links between depression, self-esteem, negative schematic beliefs and delusions and hallucinations.  Schizophr Res. 2006;  86 181-188
  • 26 Guillem F, Pampoulova T, Stip E, Lalonde P, Todorov C. The relationships between symptom dimensions and dysphoria in schizophrenia.  Schizophr Res. 2005;  75 83-96
  • 27 Häfner H, Maurer K, Trendler G. et al . Schizophrenia and depression: challenging the paradigm of two separate diseases – a controlled study of schizophrenia, depression and healthy controls.  Schizophr Res. 2005;  77 11-24
  • 28 Birchwood M, Iqbal Z, Upthegrove R. Psychological pathways to depression in schizophrenia: studies in acute psychosis, post psychotic depression and auditory hallucinations.  Eur Arch Psychiatry Clin Neurosci. 2005;  255 202-212
  • 29 Bentall R P, Corcoran R, Howard R, Blackwood N, Kinderman P. Persecutory delusions: a review and theoretical integration.  Clin psychol rev. 2001;  21 1143-1192
  • 30 Morrison A P, Nothard S, Bowe S E, Wells A. Interpretations of voices in patients with hallucinations and non-patient controls: a comparison and predictors of distress in patients.  Behav Res Ther. 2004;  42 1315-1323
  • 31 Garety P A, Kuipers E, Fowler D, Freeman D, Bebbington P E. A cognitive model of the positive symptoms of psychosis.  Psychol Med. 2001;  31 189-195
  • 32 Hemsley D R. Schizophrenia. A cognitive model and its implications for psychological intervention.  Behav Mod. 1996;  20 139-169
  • 33 Freeman D, Garety P A, Kuipers E, Fowler D, Bebbington P E. A cognitive model of persecutory delusions.  Brit J Clin Psychol. 2002;  41 331-347
  • 34 Freeman D, Garety P A, Kuipers E. et al . Acting on persecutory delusions: the importance of safety seeking.  Behav Res Ther. 2007;  45 89-99
  • 35 Favrod J, Grasset F, Spreng S, Grossenbacher B, Hode Y. Benevolent voices are not so kind: the functional significance of auditory hallucinations.  Psychopathology. 2004;  37 304-308
  • 36 Copolov D L, Mackinnon A, Trauer T. Correlates of the affective impact of auditory hallucinations in psychotic disorders.  Schizophr Bull. 2004;  30 163-171
  • 37 Romme M A, Honig A, Noorthoorn E O, Escher A D. Coping with hearing voices: an emancipatory approach.  Brit J Psychiat. 1992;  161 99-103
  • 38 Carter D M, Mackinnon A, Copolov D L. Patients' strategies for coping with auditory hallucinations.  J Nerv Ment Dis. 1996;  184 159-164
  • 39 Birchwood M, Meaden A, Trower P, Gilbert P, Plaistow J. The power and omnipotence of voices: subordination and entrapment by voices and significant others.  Psychol Med. 2000;  30 337-344
  • 40 Close H, Garety P. Cognitive assessment of voices: further developments in understanding the emotional impact of voices.  Brit J Clin Psychol. 1998;  37 (Pt 2) 173-188
  • 41 Tien A Y. Distributions of hallucinations in the population.  Soc Psych Psych Epid. 1991;  26 287-292
  • 42 Valmaggia L R, van der Gaag M, Tarrier N, Pijnenborg M, Slooff C J. Cognitive-behavioural therapy for refractory psychotic symptoms of schizophrenia resistant to atypical antipsychotic medication. Randomised controlled trial.  Br J Psychiat. 2005;  186 324-330
  • 43 Hacker D, Birchwood M, Tudway J, Meaden A, Amphlett C. Acting on voices: omnipotence, sources of threat, and safety-seeking behaviours.  Br J Clin Psychol. 2007 Oct 23; 
  • 44 Sanjuan J, Gonzalez J C, Aguilar E J, Leal C, van Os J. Pleasurable auditory hallucinations.  Acta Psychiat Scand. 2004;  110 273-278
  • 45 Miller L J, O'Connor E, DiPasquale T. Patients' attitudes toward hallucinations.  Am J Psychiat. 1993;  150 584-588
  • 46 Chadwick P, Birchwood M. The omnipotence of voices. A cognitive approach to auditory hallucinations.  Brit J Psychiay. 1994;  164 190-201
  • 47 Miller L J. Qualitative changes in hallucinations.  Amer J Psychiat. 1996;  153 265-267
  • 48 Kay S R, Fiszbein A, Opler L A. The positive and negative syndrome scale (PANSS) for schizophrenia.  Schizophr Bull. 1987;  13 261-276
  • 49 Bell M D, Lysaker P H, Beam-Goulet J L, Milstein R M, Lindenmayer J P. Five-component model of schizophrenia: assessing the factorial invariance of the positive and negative syndrome scale.  Psychiat Res. 1994;  52 295-303
  • 50 Conley R R. Evaluating clinical trial data: outcome measures.  J Clin Psychiat. 2001;  62, Suppl 9 23-26
  • 51 Mass R, Schoemig T, Hitschfeld K, Wall E, Haasen C. Psychopathological syndromes of schizophrenia: evaluation of the dimensional structure of the positive and negative syndrome scale.  Schizophr Bull. 2000;  26 (1) 167-177
  • 52 Naber D. A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables.  Int Clin Psychopharm. 1995;  10, Suppl 3 133-138
  • 53 Pukrop R, Moller H J, Sass H. et al . Das Konstrukt Lebensqualität Metaanalytische Validierung und die Entwicklung eines modularen Erhebungssystems.  Nervenarzt. 1999;  70 41-53
  • 54 Moritz S, Werner R, Collani G V. The inferiority complex in paranoia re-addressed. A study with the Implicit Association Test.  Cognit Neuropsych. 2006;  11 402-415
  • 55 Rosenheck R, Stroup S, Keefe R S. et al . Measuring outcome priorities and preferences in people with schizophrenia.  Brit J Psychiat. 2005;  187 529-536
  • 56 Offen L, Waller G, Thomas G. Is reported childhood sexual abuse associated with the psychopathological characteristics of patients who experience auditory hallucinations?.  Child Abuse Neglect. 2003;  27 919-927
  • 57 Hardy A, Fowler D, Freeman D. et al . Trauma and hallucinatory experience in psychosis.  J Nerv Ment Dis. 2005;  193 501-507
  • 58 Gaudiano B A, Herbert J D. Acute treatment of inpatients with psychotic symptoms using Acceptance and Commitment Therapy: pilot results.  Behav Res Ther. 2006;  44 415-437
  • 59 Bach P, Hayes S C. The use of acceptance and commitment therapy to prevent the rehospitalization of psychotic patients: a randomized controlled trial.  J Consult Clin Psychol. 2002;  70 1129-1139
  • 60 Sibitz I, Gossler R, Katschnig H, Amering M. „Wissen – genießen – besser leben” – Ein Seminar für Psychoseerfahrene zur Verbesserung der Lebensqualität und Verringerung der Verletzlichkeit.  Psychiat Prax. 2006;  33 170-176

Dr. Anne Karow

Zentrum für Psychosoziale Medizin, Klinik für Psychiatrie und Psychotherapie, Universitätsklinikum Hamburg-Eppendorf

Martinistraße 52

20246 Hamburg

Email: karow@uke.uni-hamburg.de